Applications: RNAi, RNAi SP
The Kir3.3 (KCNJ9) encodes for a 393 amino acid long, 44 kDA, G-protein activated inward rectifier potassium channel protein that creates heteromultimeric pore-forming complexes. The Kir3.3 gene has been investigated in generalized epilepsy, meniere's disease, pertussis, lung cancer, schizophrenia, and diabetes mellitus. It interacts with the DRD4, KCNJ6, ADRB2, KCNJ3, and DRD2 genes in potassium transporting pathways (inward and outward), G-Beta gamma signaling, neurotransmitter receptor binding and downward transmission in the postsynaptic cell, and ion currents in synaptic transmission.
|Product By Gene ID
- inwardly rectifier K+ channel KIR3.3
- G protein-coupled inward rectifier potassium channel
- Potassium channel, inwardly rectifying subfamily J member 9
- G protein-activated inward rectifier potassium channel 3
- Inward rectifier K(+) channel Kir3.3
- potassium inwardly-rectifying channel, subfamily J, member 9
PTMs for Kir3.3
Learn more about PTMs related to Kir3.3.Glycosylation
Bioinformatics Tool for Kir3.3
Discover related pathways, diseases and genes to Kir3.3. Need help? Read the Bioinformatics Tool Guide
for instructions on using this tool.